Latest stories on IVVD
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
TipRanks28 · bearishgeneral
Invivyd, Inc. (IVVD) files 8-K
SEC 8-K34 · bearishgeneral
IVVD Stock Drops As PEMGARDA Loses Emergency Authorization In 2027 — Invivyd Eyes Full FDA Approval
Stocktwits News38 · neutralgeneral
Invivyd gets notice of Pemgarda EUA termination
Seeking Alpha32 · bearishgeneral
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
TipRanks59 · neutralproduct/pr
Invivyd, Inc. (IVVD) files 8-K
SEC 8-K50 · neutralgeneral
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IVVD Stock News
StockTitan50 · neutralgeneral
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration | IVVD Stock News
StockTitan59 · neutralproduct/pr
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IVVD Stock News
StockTitan50 · neutralgeneral
Invivyd to Participate in Upcoming Investor Events | IVVD Stock News
StockTitan56 · neutralgeneral
Invivyd Shareholders Reelect Board, Ratify PwC Auditor
TipRanks50 · neutralgeneral
Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now
Yahoo Top57 · neutralanalyst
Invivyd, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Invivyd outlines VYD2311 path as PEMGARDA grows 22% year-over-year while DECLARATION recruitment nears completion
Seeking Alpha63 · neutralproduct/pr
Invivyd, Inc. (IVVD) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Invivyd GAAP EPS of -$0.13, revenue of $13.74M
Seeking Alpha42 · neutralearnings